Arcutis Biotherapeutics (ARQT) Insider Trading & Ownership

Arcutis Biotherapeutics logo
$26.49 -0.17 (-0.65%)
As of 09:30 AM Eastern
This is a fair market value price provided by Massive. Learn more.

Arcutis Biotherapeutics (NASDAQ:ARQT) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
9.40%
Number Of
Insiders Buying
(Last 12 Months)
0
Number Of
Insiders Selling
(Last 12 Months)
9
Amount Of
Insider Selling
(Last 12 Months)
$15.72M
Get ARQT Insider Trade Alerts

Want to know when executives and insiders are buying or selling Arcutis Biotherapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

ARQT Insider Buying and Selling by Quarter

Arcutis Biotherapeutics Insider and Congressional Trades History

Transaction DateInsiderBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
6/17/2026Sell635$25.67$16,300.45  
6/15/2026Sell4,096$24.41$99,983.36  
6/15/2026
Sue-Jean Lin
Sue-Jean Lin
Director
Sell4,946$24.38$120,583.48  
5/29/2026Buy$21.46$1,001 - $15,000
5/11/2026Sell435$21.05$9,156.75  
5/11/2026Sell222$21.05$4,673.10  
5/4/2026Sell1,341$23.61$31,661.01  
5/4/2026Sell8,256$23.31$192,447.36  
5/4/2026Sell684$23.61$16,149.24  
5/4/2026Sell3,172$23.61$74,890.92  
5/1/2026Sell7,144$22.99$164,240.56  
4/1/2026Sell10,000$23.88$238,800.00  
3/3/2026Buy$23.60$1,001 - $15,000
3/2/2026Sell3,687$25.18$92,838.66  
3/2/2026Sell2,853$25.18$71,838.54  
3/2/2026Sell8,733$25.30$220,944.90  
3/2/2026Sell6,287$25.18$158,306.66  
3/2/2026Sell37,349$25.18$940,447.82  
2/27/2026Sell3,325$27.95$92,933.75  
2/4/2026Sell9,794$25.81$252,783.14  
2/2/2026Sell10,000$25.05$250,500.00  
2/2/2026Sell2,052$25.50$52,326.00  
2/2/2026Sell1,320$25.50$33,660.00  
2/2/2026Sell40,638$25.28$1,027,328.64  
2/2/2026Sell3,675$25.50$93,712.50  
2/2/2026Sell19,833$25.50$505,741.50  
1/5/2026Sell2,490$28.98$72,160.20  
1/2/2026Sell10,000$28.96$289,600.00  
12/31/2025Sell1,697$29.20$49,552.40  
12/15/2025Sell11,500$28.94$332,810.00  
12/11/2025Sell$29.47$1,001 - $15,000
12/1/2025Sell10,000$30.21$302,100.00  
12/1/2025Sell1,657$30.23$50,091.11  
11/24/2025
Sue-Jean Lin
Sue-Jean Lin
Director
Sell25,272$30.78$777,872.16  
11/24/2025Sell48,945$30.36$1,485,970.20  
11/21/2025Sell1,055$30.00$31,650.00  
11/20/2025Sell16,532$27.55$455,456.60  
11/19/2025Sell2,550$28.29$72,139.50  
11/13/2025Sell40,504$23.20$939,692.80  
11/6/2025Sell29,131$25.16$732,935.96  
11/6/2025Sell17,250$24.18$417,105.00  
11/5/2025Sell3,864$23.72$91,654.08  
11/3/2025Sell10,000$25.27$252,700.00  
Big Oil knew about this for 50 years (Ad)

In the 1970s, Chevron, Unocal, and Texaco all drilled the same energy source - and walked away to protect oil profits. One company spent sixty years quietly proving them wrong. Now Google has signed a 15-year contract, Bill Gates has committed $100 million, and a July 4th government decision could hand this sector its biggest catalyst yet. The oil majors are scrambling back in, but one company already owns the entire chain.tc pixel

See the company Big Oil may be too late to stop
11/3/2025Sell88$24.72$2,175.36  
11/3/2025Sell7,208$24.72$178,181.76  
11/3/2025Sell2,622$24.72$64,815.84  
11/3/2025Sell11,547$24.72$285,441.84  
10/28/2025Sell40,000$25.03$1,001,200.00  
10/2/2025Sell4,504$20.04$90,260.16  
10/2/2025Sell20,739$20.04$415,609.56  
10/1/2025Sell10,000$18.92$189,200.00  
10/1/2025Sell24,261$19.33$468,965.13  
9/9/2025Sell504$17.52$8,830.08  
9/8/2025Sell9,625$17.54$168,822.50  
9/4/2025Sell36,130$16.16$583,860.80  
9/2/2025Sell10,000$15.64$156,400.00  
8/21/2025Sell2,438$15.57$37,959.66  
8/19/2025Sell1,750$16.16$28,280.00  
8/8/2025Sell3,847$14.03$53,973.41  
8/4/2025Sell89$14.33$1,275.37  
8/4/2025Sell6,330$14.33$90,708.90  
8/4/2025Sell2,622$14.33$37,573.26  
8/4/2025Sell11,547$14.33$165,468.51  
8/1/2025Sell10,000$14.30$143,000.00  
7/14/2025Sell5,750$15.07$86,652.50  
7/10/2025Sell23,000$15.05$346,150.00  
(Data available from 1/1/2013 forward)

ARQT Insider Trading Activity - Frequently Asked Questions

9.40% of Arcutis Biotherapeutics stock is owned by insiders. Learn more on ARQT's insider holdings.

The following insiders have purchased ARQT shares in the last 24 months: Larry Todd Edwards ($7,771.23), and Patrick J Heron ($99,276.66).

Insiders have purchased a total of 8,527 ARQT shares in the last 24 months for a total of $107,047.89 bought.

The following insiders have sold ARQT shares in the last 24 months: David Joseph Topper ($110,214.48), Halley E Gilbert ($455,456.60), Howard G Welgus ($3,245,882.80), Larry Todd Edwards ($1,110,483.60), Latha Vairavan ($149,767.03), Masaru Matsuda ($2,823,585.92), Neha Krishnamohan ($939,692.80), Patrick Burnett ($2,619,244.47), Sue-Jean Lin ($898,455.64), Terrie Curran ($94,253.95), Todd Franklin Watanabe ($274,962.00), and Todd Watanabe ($5,553,038.06).

Insiders have sold a total of 882,505 Arcutis Biotherapeutics shares in the last 24 months for a total of $18,275,037.35 sold.

Gilbert Ray Cisneros, Jr. (D-CA) has bought shares of Arcutis Biotherapeutics in the last year totaling $16,000. Gilbert Ray Cisneros, Jr. (D-CA) has sold shares totaling $8,000.



This page (NASDAQ:ARQT) was last updated on 6/24/2026 by MarketBeat.com Staff.
From Our Partners